Keeping you up to date on recent developments in neurology, including: Three stages to COVID-19 brain damage identified; ApoE4’s role in Alzheimer’s blood vessels; Lifespan synaptic atlas gives developmental insights.
Keeping you up to date on recent developments in diagnostics, including: Sickle cell still greatly undiagnosed; Cardiac imaging for heart strain in infants with lung infections; C12orf49 is new lipid metabolism gene.
Keeping you up to date on recent developments in oncology, including: Hydrogen peroxide stimulates gold nanorods, paclitaxel, for cancer treatment; Oncometabolites mask DNA repair signals; Stress-induced mutagenesis leads to cancer drug resistance; Nanomotoring in bladder cancer.
Keeping you up to date on recent developments in cardiology, including: Stroke protection effects like night and day; Blood pressure meds help range of patients when taken as prescribed; Test IDs undetected blood clots in COVID-19 patients.
From memory formation to waste clearance, sleep, Dragana Rogulja said, is thought of as “of the brain, by the brain, for the brain.” However, sleep may be necessary for the brain, but the brain is not necessary for sleep.
BioWorld looks at translational medicine, including: Healthspan, lifespan affected differently by caloric restriction; Stroke protection effects like night and day; Oncometabolites mask DNA repair signals; Antiviral vaccine protects against myocarditis, diabetes; C12orf49 is new lipid metabolism gene; Base editing gives temporary hearing fix; Simultaneous dual base editing; Nuclear quality control by chaperones; Stress-induced mutagenesis leads to cancer drug resistance.
Keeping you up to date on recent developments in diagnostics, including: Improving diagnosis of prostate cancer; Assay system identifies mitochondria-targeting drugs for PD; Ovarian organoids implicate oviducts.
Two major papers on repurposed drugs for COVID-19 by researchers from Brigham and Women’s Hospital face intense skepticism from the research community, prompting the editorial boards of TheNew England Journal of Medicine and The Lancet to publish Expressions of Concern on the validity of the underlying data. Such expressions are often the first step toward an outright retraction.
Keeping you up to date on recent developments in oncology, including: Hydrogen plus gemcitabine may prove efficacious in treatment of bladder cancer; Tumor types have distinct microbiomes; Kinase helps prepare pre-metastatic niche; EZH2 has dual role; Sulfur-for-oxygen switch enables photosensitizers for cancer therapy.
